A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Safety and Efficacy of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents (SLIMMER-YOUNG)
Sponsor study identifier
interventional
192
1 country
1
Study Start
October 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
June 8, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
September 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The aim of the study is to evaluate the safety and efficacy of Ecnoglutide injection in overweight or obese Chinese adolescents
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 14, 2026
Actual (reported)September 23, 2026
Actual (reported)October 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
June 8, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
September 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Percent change in Body Mass Index (BMI)
Baseline, week 40
Percentage of participants with ≥5% of BMI reduction
Baseline, week 40 and week 52
Change in BMI
Baseline, week 52
Percentage of participants with ≥10% of BMI reduction
Baseline, week 52
Percentage of participants with ≥15% of BMI reduction
Baseline, week 52
Percentage of participants with ≥20% of BMI reduction
Baseline, week 52
once weekly
once weekly
once weekly
Subcutaneous injection
Subcutaneous injection
Children's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Junfen Fu, Dr
The Children's Hospital of Zhejiang University School of Medicine
First Submitted
September 14, 2026
First Posted
September 23, 2026
Study Start
October 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
June 8, 2028
once weekly
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
September 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
September 23, 2026
Record last verified: 2026-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: